Literature DB >> 7739892

Sequence context of antisense RelA/NF-kappa B phosphorothioates determines specificity.

J Y Maltese1, H W Sharma, L Vassilev, R Narayanan.   

Abstract

The use of antisense oligomers to achieve inhibition of gene expression is complicated by frequent non-specific effects, and even the control oligomers often exhibit sequence-specific effects. We have recently shown that in diverse tumor-derived cell lines, a 24mer phosphorothioate oligomer antisense to the relA subunit of NF-kappa B transcription factor causes a block of cellular adhesion, inhibition of nuclear NF-kappa B and Sp1 DNA-binding activity and inhibition of tumor cell growth in vitro and in vivo. In this study we use the same model to attempt to define the limits of antisense specificity. We demonstrate that single base pair substitution can virtually abolish the antisense activity. The relative position of mismatches within the antisense sequence is critical to the loss of activity. Our results further indicate that antisense specificity is determined not only by the content of the sequence but also by its occurrence with reference to the surrounding sequences.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7739892      PMCID: PMC306823          DOI: 10.1093/nar/23.7.1146

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  32 in total

1.  Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NF-kappa B.

Authors:  S M Ruben; P J Dillon; R Schreck; T Henkel; C H Chen; M Maher; P A Baeuerle; C A Rosen
Journal:  Science       Date:  1991-03-22       Impact factor: 47.728

Review 2.  Specific regulation of gene expression by antisense, sense and antigene nucleic acids.

Authors:  C Hélène; J J Toulmé
Journal:  Biochim Biophys Acta       Date:  1990-06-21

3.  Effect of human T-cell leukemia virus type I tax protein on activation of the human vimentin gene.

Authors:  A Lilienbaum; M Duc Dodon; C Alexandre; L Gazzolo; D Paulin
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

Review 4.  Gene inhibition using antisense oligodeoxynucleotides.

Authors:  R W Wagner
Journal:  Nature       Date:  1994-11-24       Impact factor: 49.962

5.  Problems in interpretation of data derived from in vitro and in vivo use of antisense oligodeoxynucleotides.

Authors:  C A Stein; A M Krieg
Journal:  Antisense Res Dev       Date:  1994

6.  An inducible transcription factor activates expression of human immunodeficiency virus in T cells.

Authors:  G Nabel; D Baltimore
Journal:  Nature       Date:  1987 Apr 16-22       Impact factor: 49.962

7.  DNA binding and I kappa B inhibition of the cloned p65 subunit of NF-kappa B, a rel-related polypeptide.

Authors:  G P Nolan; S Ghosh; H C Liou; P Tempst; D Baltimore
Journal:  Cell       Date:  1991-03-08       Impact factor: 41.582

8.  An NF kappa B-like factor is essential but not sufficient for cytokine induction of endothelial leukocyte adhesion molecule 1 (ELAM-1) gene transcription.

Authors:  J Whelan; P Ghersa; R Hooft van Huijsduijnen; J Gray; G Chandra; F Talabot; J F DeLamarter
Journal:  Nucleic Acids Res       Date:  1991-05-25       Impact factor: 16.971

Review 9.  Antisense therapy of cancer.

Authors:  R Narayanan
Journal:  In Vivo       Date:  1994 Nov-Dec       Impact factor: 2.155

10.  Fibronectin attachment activates the NF-kappa B p50/p65 heterodimer in fibroblasts and smooth muscle cells.

Authors:  E E Qwarnström; C O Ostberg; G L Turk; C A Richardson; K Bomsztyk
Journal:  J Biol Chem       Date:  1994-12-09       Impact factor: 5.157

View more
  6 in total

Review 1.  Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer.

Authors:  Paula J Bates; Damian A Laber; Donald M Miller; Shelia D Thomas; John O Trent
Journal:  Exp Mol Pathol       Date:  2009-01-20       Impact factor: 3.362

2.  Temperature and salt dependence of higher order structure formation by antisense c-myc and c-myb phosphorothioate oligodeoxyribonucleotides containing tetraguanylate tracts.

Authors:  S Basu; E Wickstrom
Journal:  Nucleic Acids Res       Date:  1997-04-01       Impact factor: 16.971

3.  Antisense treatment directed against mutated Ki-ras in human colorectal adenocarcinoma.

Authors:  H J Andreyev; P J Ross; D Cunningham; P A Clarke
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

4.  Formation of a G-tetrad and higher order structures correlates with biological activity of the RelA (NF-kappaB p65) 'antisense' oligodeoxynucleotide.

Authors:  L Benimetskaya; M Berton; A Kolbanovsky; S Benimetsky; C A Stein
Journal:  Nucleic Acids Res       Date:  1997-07-01       Impact factor: 16.971

5.  Multiple mechanisms may contribute to the cellular anti-adhesive effects of phosphorothioate oligodeoxynucleotides.

Authors:  Z Khaled; L Benimetskaya; R Zeltser; T Khan; H W Sharma; R Narayanan; C A Stein
Journal:  Nucleic Acids Res       Date:  1996-02-15       Impact factor: 16.971

6.  Contiguous four-guanosine sequence in c-myc antisense phosphorothioate oligonucleotides inhibits cell growth on human lung cancer cells: possible involvement of cell adhesion inhibition.

Authors:  Y Saijo; B Uchiyama; T Abe; K Satoh; T Nukiwa
Journal:  Jpn J Cancer Res       Date:  1997-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.